Current stock page

Catalysts

CLOV Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareMedical - Healthcare PlansScore data as of Oct 30, 2026

CLOVClover Health Investments, Corp.

Healthcare / Medical - Healthcare Plans

Low Priority

Relative Laggard

NeutralEdge 2/10
$4.46−$0.12 (−2.62%)

Latest quote

  • Momentum
    56
  • Value
    42
  • Quality
    38
  • Risk resilience
    33
  • Sentiment
    —
algovestiq.comScore data as of Oct 30, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
—

No upcoming reporting date is available yet.

AIQ Catalyst
AIQ 43/100

Momentum 56/100 and sentiment — before the next covered event.

Recent coverage
0 articles

Updated — · Sentiment not scored

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 56/100AIQ Edge 2/10 Relative Laggard
Beat rate
57%
4 of 7 reported periods
Average surprise
-24.6%
Across covered historical reports
Latest result
+29.4%
Aug 5, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 4, 2026—-$0.00——$740.31M—
Aug 5, 2026—$0.04$0.05+29.4%$728.27M$743.17M
May 6, 2026—$0.07$0.07+0.0%$714.89M$749.19M
Feb 26, 2026—-$0.10-$0.05+51.0%$467.06M$487.71M
Nov 4, 2025—$0.02-$0.05-350.0%$467.06M$496.65M
Aug 5, 2025—-$0.01-$0.02-116.7%$468.3M$477.62M
May 6, 2025—-$0.07$0.05+171.4%$466.93M$462.33M
Feb 27, 2025—-$0.07-$0.04+42.9%$347.41M$336.96M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
—
-
covered analysts
No rating distribution in this snapshot.
12-month analyst target
—
— versus current price
Based on available analyst observations. Targets are estimates, not predictions.
No analyst target path in this snapshot.
Low target
—
—
Average target
—
—
High target
—
—

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event date—

Upcoming earnings date not available yet.

Sentiment score—

News pressure around the setup.

Momentum score56

Where event reaction would show up first.

AIQ score43/100

Composite decision read before event confirmation.

Analyst context

Analyst targets and estimate revisions are not included in the current coverage.

News And Sentiment

Recent company coverage, scored where source sentiment is available.

No recent articles have a scored sentiment label.
Positive
0
Neutral
0
Negative
0

No recent company-specific news is available.

Open full news and sentiment

CLOV Catalysts FAQ

What are the next catalysts for CLOV stock?

CLOV's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move CLOV stock?

Upcoming events that could move CLOV include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could CLOV's next earnings report affect the stock?

CLOV's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive CLOV stock higher?

CLOV could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt CLOV stock?

CLOV could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.